Recent Company News

• 10:42 AM ET Dec 15, 2025
  

  MHRA approves reclassification of fluticasone propionate (Pirinase Allergy 0.05% w/w Nasal Spray) as over-the-counter allergy treatment for adolescents aged 12 and over

• 02:04 AM ET Nov 10, 2025
  

  Haleon announces resignation of Sir Dave Lewis as Chair as of 31-Dec-25; appoints Vindi Banga as successor with effect from 1-Jan-26 (361.2000p, 0)

• 07:08 AM ET Oct 30, 2025
  

  Transcript Intelligence: Haleon Q3 Earnings Themes (345.0000p, +1)

• 07:08 AM ET Oct 30, 2025
  

  Transcript Intelligence: Haleon Q3 Earnings Guidance (345.0000p, +1)

• 07:07 AM ET Oct 30, 2025
  

  Transcript Intelligence: Haleon Q3 Earnings Q&A (345.0000p, 0)

• 03:23 AM ET Oct 30, 2025
  

  StreetAccount Metrics Recap - Haleon Q3 Sales (344.9000p, 0)

• 03:07 AM ET Oct 30, 2025
  

  Haleon Q3 trading statement; reports revenues €2.80B vs consensus £2.78B; on track to deliver FY guidance (344.9000p, 0)

• 12:14 PM ET Oct 28, 2025
  

  StreetAccount Consensus Metrics Preview - Haleon Q3 Revenue (344.5000p, -1.4)

• 01:08 PM ET Oct 08, 2025
  

  StreetAccount Summary - US unusual volume traders

• 10:06 AM ET Sep 25, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (106 total)